30 Under 30 Healthcare 2025: Advancing AI, Delivering Care And Creating New Therapies [Forbes]
Blueprint Medicines Corporation (BPMC)
Last blueprint medicines corporation earnings: 2/13 07:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
blueprintmedicines.com
Company Research
Source: Forbes
By Katie Jennings Alex Knapp and Genevieve Bookwalter N ot all cancers are created equally, which means that how to treat them can depend on a variety of factors. But those specifics aren't always easy for doctors to find. Enter Anirudh Joshi and his company, Valar Labs. It uses AI to analyze an image of a tumor for patients with bladder cancer, which provides data doctors can use to determine the best way to move forward. “AI is going to completely change and create an abundance of healthcare,” he says. “And this is across all domains, not just for what we do.” So far, 20 hospitals around the country are using Valar Labs' software, and next up for the company is training its models to analyze other types of cancer, such as pancreatic cancer and lymphoma. To that end, it's raised $26 million from venture capitalists so far, and Joshi, 29, says Valar Labs could be “the next billion dollar company in cancer.” Tim Tadder for Forbes Joshi, along with his cofounders Damir Vrabac
Show less
Read more
Impact Snapshot
Event Time:
BPMC
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BPMC alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BPMC alerts
High impacting Blueprint Medicines Corporation news events
Weekly update
A roundup of the hottest topics
BPMC
News
- Blueprint Medicines Co. (NASDAQ: BPMC) had its "overweight" rating re-affirmed by analysts at Stephens. They now have a $140.00 price target on the stock.MarketBeat
- Blueprint Medicines to Present at the 43rd Annual J.P. Morgan Healthcare Conference [Yahoo! Finance]Yahoo! Finance
- Blueprint Medicines to Present at the 43rd Annual J.P. Morgan Healthcare ConferencePR Newswire
- Blueprint Medicines Co. (NASDAQ: BPMC) had its "buy" rating re-affirmed by analysts at Guggenheim.MarketBeat
- Blueprint Medicines Co. (NASDAQ: BPMC) had its "market outperform" rating re-affirmed by analysts at JMP Securities. They now have a $125.00 price target on the stock.MarketBeat
BPMC
Earnings
- 10/30/24 - Beat
BPMC
Sec Filings
- 12/20/24 - Form 4
- 12/20/24 - Form 4
- 12/19/24 - Form 144
- BPMC's page on the SEC website